abcdefghijklmn
opqrstuvwxyz
Test Menu
Test Change Details
Allergy & Immunology
Cardiology & Coagulation
Dermatopathology
Endocrinology
Gastroenterology
Genetics
Hepatology
Infectious Disease
Microbiology
Nephrology
Neurology
Oncology
Pathology
Pediatrics
Rheumatology
Toxicology
Urology
Women's Health
4675U: Pain Management Profile 3 without Confirmation, Urine Print View
Creatinine S  > 19.9  mg/dL 
Specific Gravity REFRACT  > 1.002   
pH S/METER  4.5 - 9   
Oxidant S  < 200  mcg/mL 
Abnormal Specimen Validity Test:      
Amphetamines IA  < 500  ng/mL 
Benzodiazepines IA  < 100  ng/mL 
Cocaine Metabolite IA  < 150  ng/mL 
Marijuana Metabolite IA  < 20  ng/mL 
Opiates IA  < 100  ng/mL 
Oxycodone IA  < 100  ng/mL 

PRIMARY
1 Urine 30 (7) mL   Room Temperature - 7 Day(s)/Refrigerated - 14 Day(s)/Frozen - 30 Day(s)  
ALTERNATE

This panel can be used to monitor patients currently prescribed pain medication for compliance to their drug therapy and to evaluate the possibility of illicit drug use.

Collect 30 mL of random urine. Ship ambient.
Setup Schedule
Monday-Saturday

Reported (Analytical Time)
Same day

CPT Code
80307

The CPT codes provided are based on AMA guidelines and are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payer being billed.

Notes
Limit of screen quantitation: Amphetamines 500 ng/mL; Benzodiazepines 100 ng/mL; Marijuana Metabolite 20 ng/mL; Cocaine Metabolite 150 ng/mL; Opiates 300 ng/mL; Oxycodone 100 ng/mL.






1996 - 2017 Quest Diagnostics Nichols Institute of Valencia
For test information, please call Client Services at 800-421-4449.

San Francisco Web Design & Database